12.0 |
72.3 |
GO:0002803 |
positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
4.1 |
16.4 |
GO:0006218 |
uridine catabolic process(GO:0006218) |
3.9 |
31.4 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
3.6 |
10.9 |
GO:0015728 |
mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
3.5 |
10.4 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
3.5 |
10.4 |
GO:0031662 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
3.0 |
8.9 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
2.8 |
8.4 |
GO:0031938 |
regulation of chromatin silencing at telomere(GO:0031938) |
2.8 |
8.4 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
2.7 |
11.0 |
GO:0010900 |
negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
2.7 |
11.0 |
GO:0042377 |
menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
2.6 |
7.8 |
GO:1904303 |
positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
2.5 |
9.9 |
GO:0030822 |
positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
2.4 |
7.2 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
2.4 |
52.3 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
2.2 |
8.9 |
GO:0010752 |
regulation of cGMP-mediated signaling(GO:0010752) |
2.2 |
4.4 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
2.1 |
6.3 |
GO:0045658 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
2.1 |
6.2 |
GO:2000309 |
activation of MAPK activity involved in innate immune response(GO:0035419) positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) |
2.0 |
6.0 |
GO:0018262 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
2.0 |
5.9 |
GO:0036058 |
filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
1.9 |
1.9 |
GO:0050819 |
negative regulation of coagulation(GO:0050819) |
1.9 |
15.0 |
GO:0010767 |
regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
1.9 |
5.6 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
1.8 |
5.4 |
GO:0071790 |
spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
1.8 |
5.3 |
GO:0001300 |
chronological cell aging(GO:0001300) |
1.7 |
3.4 |
GO:0018894 |
dibenzo-p-dioxin metabolic process(GO:0018894) |
1.7 |
15.1 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
1.7 |
5.0 |
GO:0048627 |
myoblast development(GO:0048627) |
1.7 |
16.6 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
1.6 |
6.5 |
GO:0010899 |
regulation of phosphatidylcholine catabolic process(GO:0010899) |
1.6 |
4.8 |
GO:0006535 |
cysteine biosynthetic process from serine(GO:0006535) |
1.6 |
1.6 |
GO:1901662 |
phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
1.6 |
4.7 |
GO:0045210 |
FasL biosynthetic process(GO:0045210) |
1.6 |
9.4 |
GO:0035803 |
egg coat formation(GO:0035803) |
1.5 |
3.0 |
GO:0050807 |
regulation of synapse organization(GO:0050807) |
1.5 |
3.0 |
GO:0072034 |
renal vesicle induction(GO:0072034) |
1.5 |
7.4 |
GO:0061143 |
alveolar primary septum development(GO:0061143) |
1.5 |
2.9 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
1.4 |
5.8 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
1.4 |
1.4 |
GO:0031291 |
Ran protein signal transduction(GO:0031291) |
1.4 |
7.2 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
1.4 |
4.3 |
GO:0070512 |
regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
1.4 |
1.4 |
GO:0014013 |
regulation of gliogenesis(GO:0014013) |
1.4 |
4.2 |
GO:1900081 |
regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
1.4 |
5.5 |
GO:0046086 |
adenosine biosynthetic process(GO:0046086) |
1.4 |
9.5 |
GO:0061370 |
testosterone biosynthetic process(GO:0061370) |
1.3 |
14.5 |
GO:0010993 |
regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
1.3 |
3.9 |
GO:1904172 |
regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
1.3 |
6.5 |
GO:0060356 |
leucine import(GO:0060356) |
1.3 |
11.4 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
1.3 |
1.3 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
1.2 |
13.7 |
GO:0060753 |
regulation of mast cell chemotaxis(GO:0060753) |
1.2 |
2.5 |
GO:0032487 |
regulation of Rap protein signal transduction(GO:0032487) |
1.2 |
9.8 |
GO:0042695 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
1.2 |
1.2 |
GO:1903438 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
1.2 |
4.9 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
1.2 |
3.6 |
GO:1901860 |
positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
1.2 |
9.5 |
GO:1900623 |
regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
1.2 |
4.8 |
GO:0019087 |
transformation of host cell by virus(GO:0019087) |
1.2 |
8.2 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
1.2 |
1.2 |
GO:0007051 |
spindle organization(GO:0007051) |
1.2 |
7.0 |
GO:0009099 |
branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
1.2 |
6.9 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
1.2 |
1.2 |
GO:1900195 |
positive regulation of oocyte maturation(GO:1900195) |
1.1 |
3.4 |
GO:0042369 |
vitamin D catabolic process(GO:0042369) |
1.1 |
5.7 |
GO:0018101 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
1.1 |
2.2 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
1.1 |
2.2 |
GO:0070859 |
positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
1.1 |
1.1 |
GO:0032425 |
positive regulation of mismatch repair(GO:0032425) |
1.1 |
4.4 |
GO:1900535 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
1.1 |
3.3 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
1.1 |
28.5 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
1.1 |
3.3 |
GO:0002835 |
negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
1.1 |
13.0 |
GO:0009629 |
response to gravity(GO:0009629) |
1.1 |
6.4 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
1.1 |
4.2 |
GO:0045575 |
basophil activation(GO:0045575) |
1.1 |
4.2 |
GO:0003366 |
cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
1.1 |
3.2 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
1.0 |
5.2 |
GO:1900425 |
negative regulation of defense response to bacterium(GO:1900425) |
1.0 |
8.3 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
1.0 |
4.1 |
GO:0090362 |
positive regulation of platelet-derived growth factor production(GO:0090362) |
1.0 |
3.0 |
GO:0019072 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
1.0 |
6.1 |
GO:0007079 |
mitotic chromosome movement towards spindle pole(GO:0007079) |
1.0 |
7.1 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
1.0 |
1.0 |
GO:0042391 |
regulation of membrane potential(GO:0042391) |
1.0 |
5.0 |
GO:0010609 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
1.0 |
6.0 |
GO:0032610 |
interleukin-1 alpha production(GO:0032610) |
1.0 |
12.9 |
GO:0001766 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
1.0 |
4.9 |
GO:0031959 |
mineralocorticoid receptor signaling pathway(GO:0031959) |
1.0 |
8.8 |
GO:2000660 |
negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
1.0 |
6.8 |
GO:0006642 |
triglyceride mobilization(GO:0006642) |
1.0 |
22.2 |
GO:0032060 |
bleb assembly(GO:0032060) |
1.0 |
2.9 |
GO:0045062 |
extrathymic T cell selection(GO:0045062) |
1.0 |
21.0 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
1.0 |
19.1 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) |
0.9 |
2.8 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
0.9 |
1.9 |
GO:0045994 |
positive regulation of translational initiation by iron(GO:0045994) |
0.9 |
6.6 |
GO:2001137 |
positive regulation of endocytic recycling(GO:2001137) |
0.9 |
2.8 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
0.9 |
26.8 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
0.9 |
1.8 |
GO:1905167 |
positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.9 |
2.8 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.9 |
3.7 |
GO:0045875 |
negative regulation of sister chromatid cohesion(GO:0045875) |
0.9 |
3.7 |
GO:1903566 |
positive regulation of protein localization to cilium(GO:1903566) |
0.9 |
0.9 |
GO:0032436 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.9 |
9.1 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
0.9 |
0.9 |
GO:0002543 |
activation of blood coagulation via clotting cascade(GO:0002543) |
0.9 |
1.8 |
GO:0046102 |
inosine metabolic process(GO:0046102) |
0.9 |
1.8 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
0.9 |
4.4 |
GO:0018126 |
protein hydroxylation(GO:0018126) peptidyl-proline hydroxylation(GO:0019511) |
0.9 |
2.6 |
GO:0006500 |
N-terminal protein palmitoylation(GO:0006500) |
0.9 |
2.6 |
GO:0044029 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.9 |
4.3 |
GO:1905040 |
vestibulocochlear nerve structural organization(GO:0021649) neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) positive regulation of retinal ganglion cell axon guidance(GO:1902336) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.9 |
2.6 |
GO:0070460 |
thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.9 |
2.6 |
GO:0003308 |
negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.9 |
9.5 |
GO:1904776 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.9 |
4.3 |
GO:0048817 |
negative regulation of hair follicle maturation(GO:0048817) |
0.8 |
1.7 |
GO:0007398 |
ectoderm development(GO:0007398) |
0.8 |
2.5 |
GO:0006427 |
histidyl-tRNA aminoacylation(GO:0006427) |
0.8 |
5.1 |
GO:0051005 |
negative regulation of lipoprotein lipase activity(GO:0051005) |
0.8 |
2.5 |
GO:0019242 |
methylglyoxal biosynthetic process(GO:0019242) |
0.8 |
2.5 |
GO:0006704 |
glucocorticoid biosynthetic process(GO:0006704) |
0.8 |
3.3 |
GO:0038195 |
urokinase plasminogen activator signaling pathway(GO:0038195) |
0.8 |
17.1 |
GO:0030502 |
negative regulation of bone mineralization(GO:0030502) |
0.8 |
5.7 |
GO:0019264 |
glycine biosynthetic process from serine(GO:0019264) |
0.8 |
0.8 |
GO:0030522 |
intracellular receptor signaling pathway(GO:0030522) |
0.8 |
4.0 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
0.8 |
3.2 |
GO:0046035 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.8 |
2.4 |
GO:0046946 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.8 |
0.8 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
0.8 |
1.6 |
GO:0060584 |
regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.8 |
2.4 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
0.8 |
1.6 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) |
0.8 |
2.3 |
GO:0086098 |
angiotensin-activated signaling pathway involved in heart process(GO:0086098) negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
0.8 |
2.3 |
GO:1902490 |
regulation of sperm capacitation(GO:1902490) |
0.8 |
3.8 |
GO:1990834 |
response to odorant(GO:1990834) |
0.8 |
0.8 |
GO:1903862 |
positive regulation of oxidative phosphorylation(GO:1903862) |
0.8 |
0.8 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
0.7 |
5.2 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
0.7 |
1.5 |
GO:1902527 |
positive regulation of protein monoubiquitination(GO:1902527) |
0.7 |
3.0 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
0.7 |
5.9 |
GO:0070813 |
hydrogen sulfide metabolic process(GO:0070813) |
0.7 |
2.2 |
GO:0035290 |
trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
0.7 |
0.7 |
GO:0010888 |
negative regulation of lipid storage(GO:0010888) |
0.7 |
0.7 |
GO:0003419 |
growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.7 |
0.7 |
GO:1901204 |
regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
0.7 |
3.7 |
GO:0002159 |
desmosome assembly(GO:0002159) |
0.7 |
3.6 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.7 |
2.9 |
GO:0070981 |
L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
0.7 |
1.4 |
GO:0032499 |
detection of peptidoglycan(GO:0032499) |
0.7 |
2.2 |
GO:0043163 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.7 |
2.2 |
GO:0098746 |
fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.7 |
3.6 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.7 |
2.2 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
0.7 |
0.7 |
GO:0072104 |
glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.7 |
3.6 |
GO:0042539 |
hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.7 |
2.1 |
GO:0071314 |
cellular response to cocaine(GO:0071314) |
0.7 |
2.1 |
GO:0006423 |
cysteinyl-tRNA aminoacylation(GO:0006423) |
0.7 |
6.3 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
0.7 |
1.4 |
GO:0002476 |
antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
0.7 |
2.1 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.7 |
2.1 |
GO:2001035 |
tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
0.7 |
2.1 |
GO:0042938 |
dipeptide transport(GO:0042938) |
0.7 |
2.1 |
GO:0070898 |
RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.7 |
3.5 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
0.7 |
3.5 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
0.7 |
3.5 |
GO:0061146 |
Peyer's patch morphogenesis(GO:0061146) |
0.7 |
0.7 |
GO:0060720 |
spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.7 |
5.5 |
GO:0006868 |
glutamine transport(GO:0006868) |
0.7 |
2.1 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
0.7 |
2.7 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
0.7 |
3.4 |
GO:0031337 |
cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
0.7 |
4.8 |
GO:0048549 |
positive regulation of pinocytosis(GO:0048549) |
0.7 |
2.0 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.7 |
3.4 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
0.7 |
4.1 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
0.7 |
2.0 |
GO:0009107 |
lipoate biosynthetic process(GO:0009107) |
0.7 |
1.3 |
GO:0046379 |
extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.7 |
2.0 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.7 |
4.0 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.7 |
82.8 |
GO:0070268 |
cornification(GO:0070268) |
0.7 |
4.7 |
GO:0070305 |
response to cGMP(GO:0070305) |
0.7 |
2.0 |
GO:0016999 |
antibiotic metabolic process(GO:0016999) |
0.7 |
4.0 |
GO:0032252 |
secretory granule localization(GO:0032252) |
0.7 |
2.0 |
GO:0018874 |
benzoate metabolic process(GO:0018874) |
0.7 |
5.3 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.7 |
0.7 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
0.7 |
3.3 |
GO:0008611 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.7 |
2.0 |
GO:0097254 |
renal tubular secretion(GO:0097254) |
0.6 |
3.9 |
GO:0010616 |
negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
0.6 |
1.9 |
GO:0035690 |
cellular response to drug(GO:0035690) |
0.6 |
0.6 |
GO:0035378 |
carbon dioxide transmembrane transport(GO:0035378) |
0.6 |
2.6 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
0.6 |
1.3 |
GO:0044878 |
mitotic cytokinesis checkpoint(GO:0044878) |
0.6 |
1.9 |
GO:0098968 |
neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
0.6 |
12.0 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
0.6 |
2.5 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
0.6 |
1.9 |
GO:0014707 |
branchiomeric skeletal muscle development(GO:0014707) |
0.6 |
3.1 |
GO:1904674 |
positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.6 |
0.6 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.6 |
3.1 |
GO:1902951 |
negative regulation of dendritic spine maintenance(GO:1902951) |
0.6 |
1.8 |
GO:1903028 |
positive regulation of opsonization(GO:1903028) |
0.6 |
0.6 |
GO:0015680 |
intracellular copper ion transport(GO:0015680) |
0.6 |
2.5 |
GO:1904647 |
response to rotenone(GO:1904647) |
0.6 |
0.6 |
GO:0036146 |
cellular response to mycotoxin(GO:0036146) |
0.6 |
3.7 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
0.6 |
2.4 |
GO:0035425 |
autocrine signaling(GO:0035425) |
0.6 |
0.6 |
GO:1903923 |
protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
0.6 |
1.8 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
0.6 |
1.8 |
GO:0016115 |
terpenoid catabolic process(GO:0016115) |
0.6 |
2.4 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.6 |
2.4 |
GO:0046104 |
thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.6 |
3.6 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
0.6 |
6.6 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.6 |
0.6 |
GO:1904862 |
inhibitory synapse assembly(GO:1904862) |
0.6 |
2.4 |
GO:0034625 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.6 |
3.6 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
0.6 |
0.6 |
GO:0010897 |
negative regulation of triglyceride catabolic process(GO:0010897) |
0.6 |
0.6 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
0.6 |
2.9 |
GO:0070384 |
Harderian gland development(GO:0070384) |
0.6 |
0.6 |
GO:0002522 |
leukocyte migration involved in immune response(GO:0002522) |
0.6 |
0.6 |
GO:0014057 |
positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.6 |
2.3 |
GO:0001189 |
RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
0.6 |
3.5 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.6 |
1.7 |
GO:1904640 |
response to methionine(GO:1904640) |
0.6 |
1.7 |
GO:0035054 |
embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.6 |
3.5 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
0.6 |
0.6 |
GO:0044848 |
biological phase(GO:0044848) |
0.6 |
1.7 |
GO:1905166 |
negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
0.6 |
2.9 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
0.6 |
1.7 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.6 |
3.4 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.6 |
6.3 |
GO:0070141 |
response to UV-A(GO:0070141) |
0.6 |
2.3 |
GO:0071224 |
cellular response to peptidoglycan(GO:0071224) |
0.6 |
3.4 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
0.6 |
2.3 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.6 |
1.7 |
GO:1904387 |
cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
0.6 |
1.7 |
GO:1904338 |
regulation of dopaminergic neuron differentiation(GO:1904338) |
0.6 |
0.6 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) |
0.6 |
1.7 |
GO:0002439 |
chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.6 |
2.2 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.6 |
1.1 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
0.6 |
0.6 |
GO:1901800 |
positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.6 |
2.2 |
GO:0090107 |
regulation of high-density lipoprotein particle assembly(GO:0090107) |
0.6 |
0.6 |
GO:0001992 |
regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.6 |
2.8 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
0.6 |
3.9 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
0.6 |
12.2 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
0.6 |
5.5 |
GO:0006469 |
negative regulation of protein kinase activity(GO:0006469) |
0.6 |
2.8 |
GO:0007418 |
ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.5 |
0.5 |
GO:0042420 |
dopamine catabolic process(GO:0042420) |
0.5 |
0.5 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
0.5 |
4.9 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
0.5 |
1.6 |
GO:0035565 |
regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) |
0.5 |
1.6 |
GO:0006532 |
aspartate biosynthetic process(GO:0006532) |
0.5 |
3.8 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.5 |
1.1 |
GO:0060574 |
intestinal epithelial cell maturation(GO:0060574) |
0.5 |
0.5 |
GO:0015966 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.5 |
5.4 |
GO:0007144 |
female meiosis I(GO:0007144) |
0.5 |
1.6 |
GO:1901994 |
meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.5 |
2.1 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
0.5 |
0.5 |
GO:1904030 |
negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.5 |
1.6 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
0.5 |
3.2 |
GO:0010836 |
negative regulation of protein ADP-ribosylation(GO:0010836) |
0.5 |
1.6 |
GO:1903964 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.5 |
5.8 |
GO:1905049 |
negative regulation of metallopeptidase activity(GO:1905049) |
0.5 |
2.1 |
GO:0060694 |
regulation of cholesterol transporter activity(GO:0060694) response to metformin(GO:1901558) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.5 |
1.6 |
GO:0048850 |
hypophysis morphogenesis(GO:0048850) |
0.5 |
2.1 |
GO:1902499 |
positive regulation of protein autoubiquitination(GO:1902499) |
0.5 |
0.5 |
GO:0031335 |
regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
0.5 |
1.0 |
GO:0035854 |
regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
0.5 |
0.5 |
GO:0016045 |
detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.5 |
1.0 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
0.5 |
4.1 |
GO:0006116 |
NADH oxidation(GO:0006116) |
0.5 |
4.1 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.5 |
2.1 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
0.5 |
2.1 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
0.5 |
1.0 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.5 |
2.1 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
0.5 |
1.5 |
GO:1903925 |
signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.5 |
4.1 |
GO:0072526 |
pyridine-containing compound catabolic process(GO:0072526) |
0.5 |
1.0 |
GO:0019448 |
cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.5 |
5.6 |
GO:0051918 |
negative regulation of fibrinolysis(GO:0051918) |
0.5 |
1.5 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
0.5 |
1.5 |
GO:0014034 |
neural crest cell fate commitment(GO:0014034) |
0.5 |
1.0 |
GO:0090235 |
regulation of metaphase plate congression(GO:0090235) |
0.5 |
1.5 |
GO:0021558 |
trochlear nerve development(GO:0021558) |
0.5 |
4.0 |
GO:0006366 |
transcription from RNA polymerase II promoter(GO:0006366) |
0.5 |
4.9 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
0.5 |
1.5 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.5 |
7.3 |
GO:0043320 |
natural killer cell degranulation(GO:0043320) |
0.5 |
3.4 |
GO:0019236 |
response to pheromone(GO:0019236) |
0.5 |
1.5 |
GO:0042450 |
arginine biosynthetic process via ornithine(GO:0042450) |
0.5 |
4.4 |
GO:0032495 |
response to muramyl dipeptide(GO:0032495) |
0.5 |
0.5 |
GO:0002585 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.5 |
1.9 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
0.5 |
2.4 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
0.5 |
5.8 |
GO:0002483 |
antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.5 |
1.0 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
0.5 |
1.0 |
GO:0045964 |
positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.5 |
4.3 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
0.5 |
2.9 |
GO:0014028 |
notochord formation(GO:0014028) |
0.5 |
1.0 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
0.5 |
2.4 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
0.5 |
7.6 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
0.5 |
8.5 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
0.5 |
3.8 |
GO:0035583 |
sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.5 |
6.1 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.5 |
0.9 |
GO:0031247 |
actin rod assembly(GO:0031247) |
0.5 |
2.3 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.5 |
0.5 |
GO:0003231 |
cardiac ventricle development(GO:0003231) |
0.5 |
9.8 |
GO:0035589 |
G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.5 |
2.3 |
GO:0060005 |
vestibular reflex(GO:0060005) |
0.5 |
0.9 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
0.5 |
2.3 |
GO:0050968 |
detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.5 |
0.5 |
GO:0001523 |
retinoid metabolic process(GO:0001523) |
0.5 |
1.4 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.5 |
0.5 |
GO:0043103 |
hypoxanthine salvage(GO:0043103) |
0.5 |
5.5 |
GO:0033227 |
dsRNA transport(GO:0033227) |
0.5 |
0.9 |
GO:0030278 |
regulation of ossification(GO:0030278) |
0.5 |
1.4 |
GO:0072656 |
maintenance of protein location in mitochondrion(GO:0072656) |
0.5 |
1.4 |
GO:0003335 |
corneocyte development(GO:0003335) |
0.5 |
3.6 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
0.5 |
0.9 |
GO:1904179 |
positive regulation of adipose tissue development(GO:1904179) |
0.5 |
2.3 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
0.4 |
0.9 |
GO:0048936 |
peripheral nervous system neuron axonogenesis(GO:0048936) |
0.4 |
0.4 |
GO:0033189 |
response to vitamin A(GO:0033189) |
0.4 |
5.8 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.4 |
2.2 |
GO:0070458 |
cellular detoxification of nitrogen compound(GO:0070458) |
0.4 |
2.7 |
GO:0006636 |
unsaturated fatty acid biosynthetic process(GO:0006636) |
0.4 |
1.3 |
GO:0003383 |
apical constriction(GO:0003383) |
0.4 |
4.4 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
0.4 |
1.3 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
0.4 |
1.3 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
0.4 |
5.7 |
GO:0010990 |
regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.4 |
0.9 |
GO:0071400 |
cellular response to oleic acid(GO:0071400) |
0.4 |
1.3 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
0.4 |
1.3 |
GO:0042214 |
terpene metabolic process(GO:0042214) |
0.4 |
0.9 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.4 |
0.4 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
0.4 |
2.6 |
GO:1901906 |
diadenosine polyphosphate metabolic process(GO:0015959) diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.4 |
1.7 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.4 |
1.3 |
GO:0007518 |
myoblast fate determination(GO:0007518) |
0.4 |
0.9 |
GO:0002384 |
hepatic immune response(GO:0002384) |
0.4 |
3.0 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
0.4 |
2.1 |
GO:0006015 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.4 |
6.8 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
0.4 |
4.2 |
GO:0010867 |
positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.4 |
0.4 |
GO:0071878 |
negative regulation of adrenergic receptor signaling pathway(GO:0071878) |
0.4 |
3.4 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
0.4 |
1.3 |
GO:1990764 |
regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.4 |
3.3 |
GO:0046618 |
drug export(GO:0046618) |
0.4 |
1.3 |
GO:0006710 |
androgen catabolic process(GO:0006710) |
0.4 |
1.3 |
GO:0016094 |
polyprenol biosynthetic process(GO:0016094) |
0.4 |
1.7 |
GO:0051775 |
response to redox state(GO:0051775) |
0.4 |
0.8 |
GO:0015722 |
canalicular bile acid transport(GO:0015722) |
0.4 |
0.4 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
0.4 |
1.6 |
GO:0085032 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.4 |
6.6 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.4 |
10.7 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.4 |
2.1 |
GO:0099590 |
neurotransmitter receptor internalization(GO:0099590) |
0.4 |
1.2 |
GO:0036333 |
hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
0.4 |
6.1 |
GO:0034063 |
stress granule assembly(GO:0034063) |
0.4 |
2.0 |
GO:0007070 |
negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
0.4 |
0.8 |
GO:0045598 |
regulation of fat cell differentiation(GO:0045598) |
0.4 |
5.3 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
0.4 |
2.8 |
GO:0090009 |
primitive streak formation(GO:0090009) |
0.4 |
6.0 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
0.4 |
7.2 |
GO:1904261 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.4 |
0.8 |
GO:0019918 |
peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.4 |
1.2 |
GO:0030070 |
insulin processing(GO:0030070) |
0.4 |
5.6 |
GO:2000587 |
negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.4 |
9.5 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
0.4 |
0.8 |
GO:1901877 |
regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.4 |
2.8 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.4 |
6.3 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
0.4 |
2.0 |
GO:2000609 |
regulation of thyroid hormone generation(GO:2000609) |
0.4 |
5.5 |
GO:0051639 |
actin filament network formation(GO:0051639) |
0.4 |
2.0 |
GO:2000504 |
positive regulation of blood vessel remodeling(GO:2000504) |
0.4 |
2.0 |
GO:0070980 |
biphenyl catabolic process(GO:0070980) |
0.4 |
0.4 |
GO:0042159 |
lipoprotein catabolic process(GO:0042159) |
0.4 |
2.7 |
GO:0061042 |
vascular wound healing(GO:0061042) |
0.4 |
1.6 |
GO:0021936 |
regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.4 |
2.0 |
GO:0055011 |
atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.4 |
3.1 |
GO:0043401 |
steroid hormone mediated signaling pathway(GO:0043401) |
0.4 |
1.6 |
GO:0033512 |
L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
0.4 |
1.2 |
GO:0035281 |
pre-miRNA export from nucleus(GO:0035281) |
0.4 |
2.3 |
|